CPC A61K 31/427 (2013.01) [A61K 31/4439 (2013.01); A61K 31/496 (2013.01); A61K 31/5377 (2013.01); A61K 45/06 (2013.01)] | 7 Claims |
1. A method for increasing circulating mesenchymal stem cells (MSC) in a subject, comprising administering to a subject in need thereof an amount effective to increase circulating MSC to a therapeutically valuable level in the subject of a compound of formula 7, 8, 9, 10, or 11 or a pharmaceutically acceptable salt thereof:
wherein the subject has a disorder selected from the group consisting of osteoarthritis, aplastic anemia, autoimmune hemolytic anemia, dermatomyositis, Graves' disease, idiopathic thrombocytopenic purpura, pemphigus/pemphigoid, polyarteritis nodosa, psoriasis, Sjögren's syndrome, granulomatosis with polyangiitis, and organ rejection, and wherein the method serves to treat the disorder.
|